Detachable Clip-assisted Endoscopic Cyanoacrylate Injection in the Treatment of Gastric Varices Under X-ray Perspective

Yu Chang1 site in 1 country6 target enrollmentMay 1, 2024

ConditionsGastric Varices Bleeding

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Gastric Varices Bleeding
Sponsor: Yu Chang
Enrollment: 6
Locations: 1
Primary Endpoint: Rebleeding rate at 6 weeks after treatment for gastric fundus varicose veins in cirrhosis
Status: Recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

A single-arm exploratory clinical study design was used to evaluate the safety and efficacy of a "modified sandwich injection" of tissue glue assisted by a detachable clip for the treatment of gastric varicose veins.

Registry

clinicaltrials.gov

Start Date

May 1, 2024

End Date

October 30, 2025

Last Updated

last year

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Yu Chang

Responsible Party

Sponsor Investigator

Principal Investigator

Yu Chang

student

Nanjing University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

•The subject voluntarily signs the informed consent for this experiment; According to clinical manifestation, laboratory examination, imaging examination, or liver biopsy in the diagnosis of liver cirrhosis patients; The endoscopy diagnosed gastric varices (gastroesophageal varices, gastroesophageal varices type 2 or type 1 isolated gastric varices type 1); High risk of gastric varices or has a history of gastric varices bleeding. The initial fluid resuscitation patients before or after the recovery hemodynamic stability; The age of 18 years old or more.

Exclusion Criteria

•\< 18 years old; Regional portal hypertension; Always have a liver transplant, via the jugular intrahepatic portal vein system bypass or splenectomy combined varices cut-out art history; A concurrent hepatorenal syndrome and/or multiple organ failure; Significant impact on survival of malignant tumor; Pregnancy or lactation; A known allergy to iodine.